Your browser doesn't support javascript.
loading
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Emergency Complex Higher-risk and Indicated Patients.
Jin, Zhi-Li; He, Tao; Peng, Li; Wu, Xiao-Yan; Fan, Di; Chen, Ming; Fan, Yong-Zhen; Guo, Yuan-Lin; Lu, Zhi-Bing; Wang, Hai-Rong.
Affiliation
  • Jin ZL; Department of Cardiovascular Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • He T; Institute of Myocardial Injury and Repair, Wuhan University, Wuhan, 430071, China.
  • Peng L; Department of Cardiovascular Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Wu XY; Institute of Myocardial Injury and Repair, Wuhan University, Wuhan, 430071, China.
  • Fan D; Department of Cardiovascular Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Chen M; Institute of Myocardial Injury and Repair, Wuhan University, Wuhan, 430071, China.
  • Fan YZ; Department of Cardiovascular Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Guo YL; Institute of Myocardial Injury and Repair, Wuhan University, Wuhan, 430071, China.
  • Lu ZB; Department of Cardiovascular Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Wang HR; Institute of Myocardial Injury and Repair, Wuhan University, Wuhan, 430071, China.
Curr Med Sci ; 43(6): 1206-1212, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37755635
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Atherosclerosis / Acute Coronary Syndrome / Percutaneous Coronary Intervention Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Curr Med Sci Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Atherosclerosis / Acute Coronary Syndrome / Percutaneous Coronary Intervention Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Curr Med Sci Year: 2023 Document type: Article Affiliation country: Country of publication: